Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 844 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR FDA Expands Endometrial Cancer Indication for Dostarlimab-gxly with Chemotherapy September 5, 2024 EMA Recommends Granting a Marketing Authorisation for Acalabrutinib July 30, 2020 FDA Approves Pralsetinib for Non-Small Cell Lung Cancer with RET Gene... September 1, 2023 2022 ASCO Annual Meeting: A New Targeted Therapy Combination for Low-Grade Brain... June 6, 2022 Load more HOT NEWS Husband Moved To Tears After Opening Christmas Gift From Wife Regular Exercise May Help Guard Breast Cancer Patients From Chemo Brain Active Surveillance for Low-Risk Prostate Cancer Continues to Rise Obesity and Alcohol Are Contributing to Increases in Bowel Cancer Rates...
